CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
-17.65%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.32B
AUM Growth
+$1.32B
(-27%)
Cap. Flow
-$75.9M
Cap. Flow
% of AUM
-5.74%
Top 10 Holdings %
Top 10 Hldgs %
65.22%
Holding
52
New
4
Increased
6
Reduced
13
Closed
10
Top Buys
| 1 |
GH Research
GHRS
|
$15.6M |
| 2 |
Edgewise Therapeutics
EWTX
|
$15.3M |
| 3 |
ARS Pharmaceuticals
SPRY
|
$13.8M |
| 4 |
BridgeBio Pharma
BBIO
|
$13.8M |
| 5 |
MTSR
Metsera, Inc. Common Stock
MTSR
|
$10.9M |
Top Sells
| 1 |
Avidity Biosciences
RNA
|
$19.2M |
| 2 |
Arcellx
ACLX
|
$16.4M |
| 3 |
ArriVent BioPharma
AVBP
|
$15.6M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
$13.4M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
$13.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
ArriVent BioPharma
AVBP
$780M
| – | – |
-585,462
| Closed | -$15.6M |
|
|
ARTV
52
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$76.7M
| – | – |
-103,633
| Closed | -$1.04M |
|